Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Rheumatology | Nephrology | Family Medicine
Disease Category: Gout (Hyperuricemia)
Location: United States, OK
Clinical Trial Details
Research Study Summary
Do you suffer from gout?
Objective of the study is to assess the efficacy and safety of
Febuxostat 40 mg QD and Febuxostat 80 mg QD, compared to
Allopurinol in subjects with hyperuricemia and gout. The
study's duration is 6 months long.
Patient Inclusion Criteria
- Male or female (18 to 85 years of age)
- History or presence of gout
Patient Exclusion Criteria
- Received ULT within 30 days of randomizing
- History of cancer, other than basal cell, within 5 years
- Rheumatoid arthritis requiring treatment
For more information,
To Learn more
Both Male and Female
Date Last Changed:
July 25, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.